The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Facchinetti, A.
Right arrow Articles by Biasi, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Facchinetti, A.
Right arrow Articles by Biasi, G.
The Journal of Immunology, 2005, 174: 5398-5406.
Copyright © 2005 by The American Association of Immunologists

A Large Number of T Lymphocytes Recognize Moloney-Murine Leukemia Virus-Induced Antigens, but a Few Mediate Long-Lasting Tumor Immunosurveillance 1

Antonella Facchinetti*, Silvia Dalla Santa*, Silvio Mezzalira*, Antonio Rosato* and Giovanni Biasi2,{dagger}

* Department of Oncology and Surgical Sciences, University of Padova, Padova, Italy; and {dagger} Department of Molecular Pathology and Experimental Therapies, Polytechnic University of the Marche, Ancona, Italy

The CD8+ T cell response to Moloney-murine leukemia virus (M-MuLV)-induced Ags is almost entirely dominated by the exclusive expansion of lymphocytes that use preferential TCRV{beta} chain rearrangements. In mice lacking T cells expressing these TCRV{beta}, we demonstrate that alternative TCRV{beta} can substitute for the lack of the dominant TCRV{beta} in the H-2-restricted M-MuLV Ag recognition. We show that, at least for the H-2b-restricted response, the shift of TCR usage is not related to a variation of the immunodominant M-MuLV epitope recognition. After virus immunization, all the potentially M-MuLV-reactive lymphocytes are primed, but only the deletion of dominant V{beta} rescues the alternative V{beta} response. The mechanism of clonal T cell "immunodomination" that guides the preferential V{beta} expansion is likely the result of a proliferative advantage of T cells expressing dominant V{beta}, due to differences in TCR affinity and/or cosignal requirements. In this regard, a CD8 involvement is strictly required for the virus-specific cytotoxic activity of CTL expressing alternative, but not dominant, V{beta} gene rearrangements. The ability of T cells expressing alternative TCRV{beta} rearrangements to mediate tumor protection was evaluated by a challenge with M-MuLV tumor cells. Although T cells expressing alternative V{beta} chains were activated and expanded, they were not able to control tumor growth in a long-lasting manner due to their incapacity of conversion and accumulation in the T central memory pool.




This article has been cited by other articles:


Home page
J. Immunol.Home page
P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck
Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential
J. Immunol., July 1, 2009; 183(1): 370 - 380.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2005 by The American Association of Immunologists, Inc. All rights reserved.